extensive disease
Recently Published Documents


TOTAL DOCUMENTS

445
(FIVE YEARS 82)

H-INDEX

36
(FIVE YEARS 5)

Diagnostics ◽  
2021 ◽  
Vol 11 (11) ◽  
pp. 2007
Author(s):  
Yuichiro Shirai ◽  
Ryosuke Fukue ◽  
Yuko Kaneko ◽  
Masataka Kuwana

Krebs von den Lungen-6 (KL-6) levels measured at baseline have been reported as a circulating biomarker useful for the detection, evaluation of severity and assessment of risk of the progression of interstitial lung disease (ILD) in patients with systemic sclerosis (SSc). In this retrospective study, longitudinal changes in serum KL-6 levels over 2 years were examined in 110 patients with SSc using prospectively collected cohort data. Serum KL-6 levels fluctuated in a significant proportion of the patients but remained stable in the remaining patients. A wide range of variability of longitudinal KL-6 levels was associated with the presence of ILD, diffuse cutaneous SSc, positive anti-topoisomerase I antibodies, negative anticentromere antibodies, increased ILD extent on high-resolution computed tomography, extensive disease, low pulmonary function parameters, high KL-6 levels at baseline and immunomodulatory treatment. Extensive disease was consistently identified as an independent factor associated with variability in KL-6 levels in different models of multiple regression analysis. We failed to demonstrate correlations between trends for KL-6 level changes during the 6 months after SSc diagnosis and ILD progression over 2 years in patients with SSc-ILD. Serum KL-6 levels fluctuate in SSc patients with ILD, especially in those with extensive disease, but the clinical utility of a serial KL-6 level measurement remains uncertain.


2021 ◽  
Vol 19 (2) ◽  
pp. 26-33
Author(s):  
Pratik Gahalaut ◽  
Mriganka Mehra ◽  
Nitin Mishra ◽  
Madhur Kant Rastogi ◽  
Vasudha Bery

Introduction Superficial tinea infections are some of the most common dermatological conditions in the elderly. Recently, few studies done showed an abrupt increase in dermatophytic infection in adults; however, similar recent studies describing dermatophytosis in the elderly are lacking. The aims and objectives of this study were to identify the epidemiological profile of dermatophytoses among the elderly population. Materials and Methods This was a single centre, observational cross-sectional study conducted at a tertiary care Medical College Hospital in North India over 12 months including patients of dermatophytosis (KOH confirmed) aged 60 years or more. Results A total of 192 patients were enrolled, among which 68.7% were males. The extensive disease was present in 56.2%. History of topical steroid usage was present in 79.2%. The mean duration of disease was 23.8 weeks among which chronic disease was seen in 25%. Various other demographic characteristics were identified. Various risk factors for extensive disease, like gender, topical steroids use, urban residence, higher socioeconomic status, longer duration of disease, positive family history, diabetics, regular alcohol and tobacco consumption, were also noted in the present study. Conclusion The present concludes increased prevalence in women, delay in seeking treatment among them, a rising proportion of chronic and extensive dermatophytosis, rising atypical clinical presentation and higher predilection for tinea cruris and onychomycosis.


Medicina ◽  
2021 ◽  
Vol 57 (10) ◽  
pp. 1005
Author(s):  
Teresa Clavaguera ◽  
Patrícia Reyner ◽  
Maria Buxó ◽  
Marta Valls ◽  
Eulàlia Armengol ◽  
...  

Background and objectives: Diffuse idiopathic skeletal hyperostosis (DISH) is a bone formation disease in which only skeletal signs are considered in classification criteria. The aim of the study was to describe different phenotypes in DISH patients based on clinicoradiological features. Materials and Methods: We evaluated 97 patients who met the Resnick or modified Utsinger classification criteria for DISH and were diagnosed at our hospital from 2004 to 2015. Patients were stratified into: (a) peripheral pattern (PP)—Resnick criteria not met but presenting ≥3 peripheral enthesopathies; (b) axial pattern (AP)—Resnick criteria met but <3 enthesopathies; and (c) mixed pattern (MP)—Resnick criteria met with ≥3 enthesopathies. Statistical analysis was carried out to identify variables that might predict classification in a given group. Results: Fifty-six of the 97 patients included (57.7%) were male and 72.2% fulfilled the Resnick criteria. Applying our classification, 39.7% were stratified as MP, 30.9% as AP and 29.4% as PP. Clinical enthesopathy was reported in 40.2% of patients during the course of the disease. Sixty-eight patients were included in a comparative analysis of variables between DISH patterns. The results showed a predominance of women (p < 0.004), early onset (p < 0.03), hip involvement (p < 0.003) and enthesitis (p < 0.001) as hallmarks of PP. Asymptomatic patients were most frequently observed in AP (28.6%, MP 3.8%, PP 5.0%) while MP was characterized by a more extensive disease. Conclusions: We believe DISH has distinct phenotypes and describe a PP phenotype that is not usually considered. Extravertebral manifestations should be included in the new classification criteria in order to cover the entire spectrum of the disease.


Immunotherapy ◽  
2021 ◽  
Author(s):  
Lei Song ◽  
Rengui Zhou ◽  
Xiangyong Li ◽  
Dejian Pan

Small-cell lung cancer (SCLC) is sensitive to chemoradiotherapy but remains to have a poor prognosis. In the immunotherapy era, chemotherapy combined with PD-L1 inhibitors has become a new first-line treatment option for advanced SCLC. The CheckMate 032 study combined a PD-1 blockade and a CTLA-4 inhibitor and found that this dual immunotherapy might be a positive treatment choice for SCLC. In our case, the patient with advanced SCLC received bevacizumab combined with dual immunotherapy over the third line with more than 12 months survival time. The overall survival time was 21.5 months from the start of the third-line treatment and 39 months from the time of extensive-disease SCLC diagnosis. The combination of a VEGF blockade and a dual immunotherapy in SCLC resulted in synergistic treatment effects. Therefore, bevacizumab might be a better adjuvant, either combined with chemotherapy or dual immunotherapy, for patients with persistent disease progression after undergoing immunotherapy.


2021 ◽  
Vol 84 (3) ◽  
pp. 525-526
Author(s):  
E Dias ◽  
R Coelho ◽  
A.C. Nunes ◽  
P Andrade ◽  
L Malheiro ◽  
...  

A 21-year-old female with ulcerative colitis presented with abdominal pain and bloody diarrhea. Laboratory studies revealed markedly elevated C-reactive protein and thrombocytosis. Flexible sigmoidoscopy revealed severe endoscopic activity with ulceration and spontaneous bleeding along rectum and sigmoid colon. Ulcerative colitis had been diagnosed 3 years before, presenting as severe and extensive disease (pancolitis). She had previously failed therapy with infliximab and vedolizumab and had recently started induction therapy with golimumab. She responded well to intravenous corticosteroids but, when switched to oral corticosteroids, there was symptomatic recurrence. Intravenous corticosteroids were re-started and she was evaluated for surgery. At this time, she developed new-onset tachycardia. Electrocardiogram revealed sinus tachycardia with heart rate of approximately 120 bpm. Because tachycardia could result from worsening colitis with potential serious complications, abdominal computerized tomography scan was performed and demonstrated mild lumen dilation and wall thickening consistent with acute colitis without evidence of pneumoperitoneum or toxic megacolon. Surprisingly, thoracic planes revealed the presence of free air dissecting mediastinal space (Figure 1). What is your diagnosis?


Sign in / Sign up

Export Citation Format

Share Document